glp-1 drugs wegovy obesity cleared of suicide warning US FDA accepts Novo Nordisk's

Lilly has announced that orforglipron would be put through clinical trials to be used as a medication for HIGH BLOOD PRESSURE and that absolutely caught my eye

Que may reduce oxLDL-induced oxidative damage by upregulating SIRT1 and AMPK (Hung et al., 2015), therefore potentially preventing oxLDL-impaired SIRT1 inhibition linked to endothelial dysfunction

In addition to being generated during respiration in mitochondria, hydrogen peroxide is also produced from various other metabolic processes in cells, including protein folding

10.1016/j.drugpo.2023.104139 42 PoplawskaM.BednarekE.NaumczukB.BlazewiczA

Corominas et al., 2022

1, 18 Oct